Article
After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccines
Rating:
0.0
Views:
34
Likes:
1
Library:
1
With Moderna's COVID-19 vaccine facing questions in Japan because of contamination incidents, its distribution partner in the country, Takeda, is firming up plans to manufacture and distribute the yet-to-be-approved Novavax vaccine. Japan has just agreed to purchase 150 million Novavax vaccine doses.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value